Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T21:26:02.769Z.
Calculation as of: 2026-10-06T21:26:02.769Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: d1ec63672bb9059a7c81afb01ad66bf7a3c22984462a5b6db64cfb48bb813223
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
Cantor Equity Partners V, Inc. Class A Ordinary Shares
Market Cap
$262.04M
EV/FCF Ratio
N/A
Market Cap
$261.39M
EV/FCF Ratio
N/A
| NAME | MARKET CAP | EV/FCF RATIO |
|---|---|---|
| Cantor Equity Partners V, Inc. Class A Ordinary Shares (CEPV) | $262.04M | N/A |
| AMR Resources Acquisition Corp Class A Ordinary Shares (AMAC)vs › | $261.73M | N/A |
| GigCapital8 Corp. (GIW)vs › | $261.45M | N/A |
| Mountain Lake Acquisition Corp. II Class A Ordinary Shares (MLAA)vs › | $261.39M | N/A |
| Art Technology Acquisition Corp. (ARTC)vs › | $261.12M | N/A |
| Virginia National Bankshares Corporation (VABK)vs › | $261.09M | N/A |
| FACT II Acquisition Corp (FACT)vs › | $260.73M | N/A |
| Soren Acquisition Corp. (SORN)vs › | $263.53M | N/A |
| Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA)vs › | $264.38M | N/A |
| ProCap Acquisition Corp (PCAP)vs › | $264.47M | N/A |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
